MWM
BIO icon

Moran Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Moran Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-899
Closed -$272K – 485
2025
Q4 		$272K Sell
899
-677
-43% -$211K 0.01% 450
2025
Q3 		$442K Sell
1,576
-423
-21% -$115K 0.01% 418
2025
Q2 		$482K Sell
1,999
-278
-12% -$65.7K 0.01% 418
2025
Q1 		$555K Sell
2,277
-152
-6% -$45.7K 0.02% 369
2024
Q4 		$798K Buy
2,429
+80
+3% +$27.2K 0.03% 315
2024
Q3 		$786K Sell
2,349
-50
-2% -$15.9K 0.02% 319
2024
Q2 		$655K Buy
2,399
+219
+10% +$63.7K 0.02% 316
2024
Q1 		$754K Buy
+2,180
New +$717K 0.02% 310

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Moran Wealth Management's BIO Position: Q1 2026 in Review

Moran Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 899 shares — an estimated $272K sold.

Moran Wealth Management first reported a position in BIO in Q1 2024 and held it in 8 quarters. The position peaked at $798K in Q4 2024. 394 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Moran Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Moran Wealth Management sold 899 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $272K.
  • Moran Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q1 2024 and held it in 8 quarters.
  • Moran Wealth Management's Bio-Rad Laboratories Class A position peaked at $798K in Q4 2024.
  • 394 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Moran Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.